EUVIMEDEUVIMED entdecken
Crossref

Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study

Jinyu Xiao, Yu Hao, Xueyao Wu, Xunying Zhao, Bin Xu, Chenghan Xiao, Wenqiang Zhang, Li Zhang, Huijie Cui, Chao Yang, Peijing Yan, Mingshuang Tang und 9 weitere

Breast Cancer Research and Treatment · 2023

DOI: 10.1007/s10549-023-06930-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2023. Verfasst von Jinyu Xiao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, West China School of Public Health and West China Fourth Hospital, S…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: the National Key R&D Program of China, National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: While crudely quantified lipoproteins have been reported to affect the risk of breast cancer, the effects of subclass lipoproteins characterized by particle size, particle number, and lipidomes remain unknown. METHODS: Utilizing nuclear magnetic resonance-based GWAS of 85 lipoprotein traits, we performed two-sample univariable Mendelian randomization (MR) to evaluate the causal relationship between each trait with breast cancer (Ncase/control = 133,384/113,789) and with its estrogen receptor (ER) subtypes. Then, we applied multivariable MR to investigate the independent effects considering both general and central obesity. RESULTS: In univariable MR, a heterogeneous effect of subclass high-density lipoproteins (HDL) was observed, in which small HDL traits (ORs ranged from 0.89 to 0.94) were associated with a decreased risk of breast cancer while non-small HDLs traits (OR ranged from 1.04 to 1.08) were associated with an increased risk of breast cancer. Very-low-density lipoproteins (VLDL) traits and serum total triglycerides (TG) were associated with a decreased risk of breast cancer (ORs ranged from 0.88 to 0.94). Similar association patterns were found for ER + subtype. In multivariable MR, only the protective effects of small HDL, VLDL and TG on ER + subtype remained significant. CONCLUSION: We identified a heterogeneous effect of subclass HDLs and a consistent protective effect of VLDL on breast cancer. Only the effects of small HDL and VLDL on ER + subtype remained robust after controlling for obesity. These findings provide new insight into the causal pathway underlying lipoproteins and breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleMendelian Randomization AnalysisLipoproteinsLipoproteins, HDLLipoproteins, VLDLTriglyceridesMagnetic Resonance SpectroscopyObesity

Stichwörter der Autor:innen

Breast cancerLipoproteinsMendelian randomizationNuclear magnetic resonance

Substanzen

LipoproteinsLipoproteins, HDLLipoproteins, VLDLTriglycerides

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Department of Epidemiology and Biostatistics, West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Department of Maternal, Child and Adolescent Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Department of Occupational and Environmental Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Department of Epidemiology and Biostatistics, Institute of Systems Epidemiology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. lijiayuan@scu.edu.cn.
  • Department of Epidemiology and Biostatistics, West China-PUMC C. C. Chen Institute of Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. lijiayuan@scu.edu.cn.

Förderung

  • the National Key R&D Program of China
  • National Natural Science Foundation of China
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • the Health Commission of Sichuan Province
  • the Key R&D Program of Sichuan, China

Zitieren

APA

Xiao, J., Hao, Y., Wu, X., Zhao, X., Xu, B., Xiao, C., Zhang, W., Zhang, L., Cui, H., Yang, C., Yan, P., Tang, M., Wang, Y., Chen, L., Liu, Y., Zou, Y., Yang, C., Yao, Y., Li, J., …, & Zhang, B. (2023). Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-023-06930-2

Vancouver

Xiao J, Hao Y, Wu X, Zhao X, Xu B, Xiao C, et al. Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study. Breast Cancer Research and Treatment. 2023. doi:10.1007/s10549-023-06930-2

BibTeX
@article{Xiao2023,
  author = {Xiao, Jinyu and Hao, Yu and Wu, Xueyao and Zhao, Xunying and Xu, Bin and Xiao, Chenghan and Zhang, Wenqiang and Zhang, Li and Cui, Huijie and Yang, Chao and Yan, Peijing and Tang, Mingshuang and Wang, Yutong and Chen, Lin and Liu, Yunjie and Zou, Yanqiu and Yang, Chunxia and Yao, Yuqin and Li, Jiayuan and Jiang, Xia and Zhang, Ben},
  title = {Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study},
  journal = {Breast Cancer Research and Treatment},
  year = {2023},
  doi = {10.1007/s10549-023-06930-2}
}
Kostenlos starten →